It's the money that counts
Pharmaceutical Technology Europe
Brussels report
As the introduction of new member states to the European Union edges closer, the debate in Brussels regarding healthcare for the enlarged Union becomes more heated. Health standards in new member states are predicted to increase, but the main worry for the usual protagonists is how will the European pharmaceutical industry fare?
This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europesubscribe here now.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
